Magnetic drug delivery of Xanthohumol to adipocytes using Ultrasmall Superparamagnetic Iron Oxide Nanoparticles.
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Introduction
According to the CDC’s National Center for Health Statistics,
more than one-third (36.5%) of U.S adults are obese. It is the
main risk factor for type-2-diabetes, hypertension,
dyslipidemia and atherosclerosis. Nutraceuticals such as
Xanthohumol have shown potential to inhibit adipogeneis,
however, their bioavailability has remained controversial.
Hence there is a need to develop targeted therapy which will
increase the concentration of Xanthohumol on adipose
tissues. Currently, magnetic drug delivery has been used to
develop targeted therapies where conventional therapies have
proven to be less effective. Among various types of
nanoparticles ultrasmall superparamagnetic iron oxide
nanoparticles (USPIO) have found considerable attention in
magnetic drug delivery as they are easy to synthesize, inert,
and are biocompatible.

Materials and Methods

Results

The presence of amine functional groups on the surface of
USPIO was quantified using ninhydrin Assay. The ninhydrin
assay revealed that 1 mg of amine functionalized UPSIO
had 22mg of amine groups. Xanthohumol was then
conjugated to the surface of amine-USPIO using via a
polyethylene glycol linker. The presence of amine and PEG
on the surface of nanoparticles was confirmed via IR (Fig 2).
The amount of Xanthohumol tagged onto the surface of
nanoparticles will be quantified using HPLC. The particle
size of the synthesized nanoparticles was evaluated using
TEM. TEM confirm the presence of spherical morphology
with average particle size of 20-25nm and the toxicity and
therapeutic potency of Xanthohumol tagged to USPIO will
be evaluated in vitro.

Figure 3: TEM images confirm the presence of
USPIO (Fe3O4 and Fe3O4 amine nanoparticles with
spherical morphology and particle size in the range
of 20-25nm.

Summary and Conclusions

The synthesized USPIO-amine would be conjugated to XN via
HOOC-PEG-COOH linker. The general reaction for the
development of XN loaded superparamagnetic iron oxide
nanoparticle is shown in scheme 1. The presence of USPIO,
USPIO-amine, and USPIO-PEG was confirmed by FTIR and the
XN loading capacity of USPIO-amine would be evaluated
using HPLC.

Development of XN Loaded Iron Oxide nanoparticles

Transmission Electron Microscopy

Ninhydrin Assay
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We have successfully loaded PEG on to the iron oxide
nanoparticles. Presence of stretching and bending vibrational
bands in the region of 2700 – 3000 cm-1 and 900-1300 cm-1 ,
respectively, confirm the presence of amine and PEG on the
USPIO nanoparticle. The evaluation of Xanthohumol onto the
surface of iron oxide nanoparticle is being characterized and
via FTIR. The percentage loading on XN on nanoparticles will
be quantified via HPLC. These XN loaded nanoparticles can
be directed to any sites on the body under the influence of
external magnetic field. This will improve the bioavailability of
Xanthohumol as well as reduce systemic toxicity if any.

c

Figure 1:

IR Spectroscopy
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Figure 2: Presence of stretching and bending vibrational bands in the region of 2700 –
3000 cm-1 and 900-1300 cm-1 , respectively, confirm the presence of amine and PEG on
the USPIO nanoparticle.

Scheme 1: Synthetic Scheme for the development of XN loaded
nanoparticles.
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